THC — TENET HEALTHCARE CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying THC?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 4 tracked investors who changed their THC position last quarter, 1 bought and 3 sold (25% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime). 0 congressional purchases, 2 sales disclosed in the last 6 months.
- +1 tracked investor added or increased positions last quarter (Steve Mandel)
- +7 tracked investors reported holding THC at their latest filing
- −3 tracked investors reduced or exited last quarter (1 reduced, 2 sold out)
- −Congressional disclosures lean toward selling (2 sales vs 0 purchases, 6 months)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About TENET HEALTHCARE CORP (THC)
TENET HEALTHCARE CORP (THC) appears in the most recent 13F filings of 7 tracked institutional investors. The largest disclosed position is held by Steve Mandel (Lone Pine Capital), valued at $426M. Across recent filings, tracked investors recorded 6 new positions, 0 increased, 2 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in THC
How many top investors track THC
Several tracked investors have exposure.
THC Ownership Composition
How TENET HEALTHCARE CORP is held across tracked investor types, based on reported 13F positions.
- Other86.1%
- Hedge Funds13.9%
Tracked investors reporting THC
- Steve MandelMar 31, 2026Lone Pine CapitalShares2.3MValue$426.2M% Portfolio3.40%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares610.9KValue$115.3M% Portfolio0.02%
- David EinhornDec 31, 2023DME Capital Management, LPShares1.3MValue$99.4M% Portfolio4.86%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares396.4KValue$74.8M% Portfolio0.03%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares8KValue$1.5M% Portfolio0.00%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares29.2KValue$5.5M% Portfolio0.01%
- Ray DalioMar 31, 2026Bridgewater AssociatesShares18.8KValue$3.5M% Portfolio0.02%
Recent activity
- Sold$0(-100.00%)Feb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- Sold$0(-100.00%)May 15, 2026
- New$355.2MFeb 17, 2026
- New$426.2MMay 15, 2026
- $60.1MNov 14, 2023
- $99.4MFeb 14, 2024
- Reduced$3.5M(-36.05%)May 15, 2026
- New$62.3KFeb 17, 2026
- Reduced$5.8K(-2.18%)Feb 13, 2026
- New$6.1KNov 13, 2025
Frequently asked questions
- How many institutional investors hold THC?
- 7 tracked institutional investors disclosed a position in THC (TENET HEALTHCARE CORP) in their most recent 13F filing.
- Who is the largest institutional holder of THC?
- Steve Mandel, Lone Pine Capital, holds the largest disclosed position in THC, valued at $426M.
- Did institutional ownership of THC increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 0 increased, 2 reduced, and 3 fully exited THC.
- Where does this THC ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.